Neil Saigal

Title: **Inventor Spotlight: Neil Saigal**

Introduction

Neil Saigal is an innovative inventor based in Fresno, CA, known for his contributions to the field of neuroscience. With a total of two patents, his work focuses on developing compounds that target serotonin 5-HT1A receptors, which are crucial for various neurological functions.

Latest Patents

Saigal's latest patents include compositions and methods related to serotonin 5-HT1A receptors. One such patent specifically discusses substituted arylpiperazinyl compounds, notably F-Mefway, which exhibit desirable in vitro and in vivo binding characteristics to the 5-HT1A receptor. These compounds are characterized by high binding affinity, optimal lipophilicity, and efficient radiolabeling with F-fluorine in a single step. Furthermore, they demonstrate high target to non-target ratios in receptor-rich regions both in vitro and in vivo, providing valuable tools for measuring 5-HT1A receptors and serotonin concentration changes in the living brain.

Career Highlights

Neil Saigal has made significant strides in his career, particularly through his work at the University of California. His research not only contributes to understanding serotonin receptors but also paves the way for potential therapeutic applications in treating neurological conditions.

Collaborations

Throughout his career, Saigal has collaborated with notable professionals, including Jogeshwar Mukherjee and Harsh Saigal, who contribute to the legal aspects of his innovations. Their combined expertise ensures that his inventions are well-protected under patent law.

Conclusion

With his pioneering research on serotonin 5-HT1A receptors, Neil Saigal continues to make a remarkable impact in the field of neuroscience. His dedication to innovation and collaboration exemplifies the spirit of modern scientific research. As he advances his work, the potential for his inventions to influence therapeutic strategies remains promising.